EdgeMarket › What Grandfield & Dodd, Llc reported owning

What Grandfield & Dodd, Llc reported owning

As filed on Form 13F for the quarter ending 2026-03-31, up to 45 days after that date. Long-only US-listed equity — shorts, bonds, cash and non-US listings are not on the form, so this is one leg of the book, not the book.

Reported value

1.8B

Positions

209

Quarter

2026-03-31

Shown below

50
largest by value
holdingvalue% of booksharesprice1y
AMAT
APPLIED MATERIALS INC /DE
91.7M5.2%268.3K492.32+205.9%
MSFT
MICROSOFT CORP
83.2M4.7%224.8K483.24-4.4%
ADI
ANALOG DEVICES INC
79.0M4.5%248.2K373.09+52.4%
GE
GENERAL ELECTRIC CO
68.8M3.9%242.6K348.37+30.7%
RTX
RTX Corp
65.0M3.7%337.1K209.91+34.1%
JCI
Johnson Controls International plc
63.1M3.6%481.6K143.05+35.0%
LIN
LINDE PLC
53.6M3.0%108.0K487.57+1.1%
unmapped CUSIP 08467070248.5M2.7%101.1K
CB
Chubb Ltd
48.2M2.7%147.8K340.99+21.9%
CACI
CACI INTERNATIONAL INC /DE/
48.1M2.7%88.5K647.39+33.0%
ALB
ALBEMARLE CORP
42.7M2.4%238.1K143.25+83.4%
ITW
ILLINOIS TOOL WORKS INC
42.5M2.4%163.2K282.29+7.7%
GOOGL
Alphabet Inc.
35.9M2.0%124.7K344.82+73.0%
PAYX
PAYCHEX INC
35.6M2.0%386.2K124.47-10.4%
ADSK
Autodesk, Inc.
35.0M2.0%146.1K253.82-12.1%
APD
Air Products & Chemicals, Inc.
32.3M1.8%111.1K305.10+4.4%
SYK
STRYKER CORP
31.9M1.8%96.9K329.45-15.9%
REGN
REGENERON PHARMACEUTICALS, INC.
28.1M1.6%36.4K834.04+41.1%
SNPS
SYNOPSYS INC
27.1M1.5%68.4K397.87-33.8%
VRSK
Verisk Analytics, Inc.
26.7M1.5%140.6K187.50-30.8%
HXL
HEXCEL CORP /DE/
26.4M1.5%326.5K93.86+54.6%
JNJ
JOHNSON & JOHNSON
26.3M1.5%107.4K270.24+51.1%
TRMB
TRIMBLE INC.
25.4M1.4%389.5K60.25-24.9%
AAPL
Apple Inc.
24.3M1.4%95.7K309.35+36.9%
GEHC
GE HealthCare Technologies Inc.
24.0M1.4%337.0K74.82+1.3%
NVS
NOVARTIS AG
24.0M1.4%156.9K158.86+24.8%
TDY
TELEDYNE TECHNOLOGIES INC
23.9M1.4%39.5K636.15+17.4%
CVX
CHEVRON CORP
23.9M1.3%115.5K205.27+34.0%
GILD
GILEAD SCIENCES, INC.
22.8M1.3%163.6K146.12+23.1%
SHEL
Shell plc
22.8M1.3%244.7K93.33+29.5%
HRL
HORMEL FOODS CORP /DE/
22.5M1.3%995.1K23.88-16.6%
DIS
Walt Disney Co
21.6M1.2%224.5K107.78-7.9%
MRK
Merck & Co., Inc.
21.1M1.2%175.8K152.55+80.2%
UL
UNILEVER PLC
19.4M1.1%340.2K64.14-10.3%
SNY
Sanofi
18.7M1.1%387.2K45.85-9.3%
XOM
ExxonMobil Holdings Corp
17.8M1.0%105.1K165.11+52.1%
PYPL
PayPal Holdings, Inc.
17.5M1.0%385.9K61.55-9.6%
PG
PROCTER & GAMBLE Co
17.2M1.0%118.9K144.68-9.3%
DEO
DIAGEO PLC
16.8M1.0%226.2K94.62-17.9%
MTD
METTLER TOLEDO INTERNATIONAL INC/
16.7M0.9%13.3K1,395.25+6.0%
PPG
PPG INDUSTRIES INC
16.0M0.9%149.9K113.63+1.4%
AZO
AUTOZONE INC
15.7M0.9%4.7K2,957.95-28.9%
ROK
ROCKWELL AUTOMATION, INC
15.7M0.9%43.7K437.08+28.7%
WY
WEYERHAEUSER CO
15.5M0.9%635.4K24.43-6.1%
DVN
DEVON ENERGY CORP/DE
15.3M0.9%305.0K49.10+45.4%
unmapped CUSIP 08467010810.8M0.6%15
LW
Lamb Weston Holdings, Inc.
10.7M0.6%252.1K53.68-2.7%
CTSH
COGNIZANT TECHNOLOGY SOLUTIONS CORP
10.5M0.6%171.5K61.87-12.2%
VRTX
VERTEX PHARMACEUTICALS INC / MA
9.7M0.5%21.7K548.05+39.0%
TMO
THERMO FISHER SCIENTIFIC INC.
9.6M0.5%19.5K629.27+27.2%

A position that grew quarter on quarter may simply reflect a higher price: if the stock rose 40% and the manager did nothing, the reported value rose 40%. Reading that as accumulation is reading the price back to yourself. More on that →

The whole archive is one click away.

Screener, filings, insider flow, backtests and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →